AIM: To evaluate endoscopic mucosal resection (EMR) in patients with high-grade dysplasia
(HGD) and/or intramucosal cancer (IMC) in Barrett's esophagus (BE). METHODS: Between …

Results: 24 patients completed the study. They underwent a total of 44 EMR sessions with a
median of 3 pieces (range 1-8) removed per session. Two patients with immediate bleeding …

Background Barrett's esophagus–related high-grade dysplasia or mucosal cancer can be
treated by endoscopic mucosal resection (EMR), but the adjacent metaplastic epithelium …

Background & Aims Barrett's esophagus (BE) with high-grade dysplasia (HGD) or
intramucosal carcinoma (IMC) is treated by complete eradication of areas of BE by …

Aim: Endoscopic therapy can be curative for BE and HGD (Tis) or EAC confined to the
mucosa (T1m). The risk of lymph node metastasis increases with the depth of mucosal …

Background & Aims: In view of the mortality and morbidity rates of esophagectomy and the
relatively large group of inoperable patients, local therapeutic techniques are required for …

The annual incidence of adenocarcinoma arising from Barrett's esophagus (BE) is
approximately 0.5%. Through a process of gradual transformation from low-grade dysplasia …

Background Chromoendoscopy is traditionally used to identify inconspicuous Barrett's
neoplasia and mark the boundaries before endoscopic mucosal resection (EMR). Trimodal …

Background There are limited data on the effect of endoscopic mucosal resection (EMR) on
changes of histopathologic diagnosis for Barrett's esophagus (BE) patients undergoing …

OBJECTIVES: Patients with Barrett's high-grade dysplasia (HGD) or early esophageal
adenocarcinoma (EAC) that is shown on biopsy alone continue to undergo esophagectomy …